Delving into the Latest Updates on Qingbaixinda (Shanghai) Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Small molecule drug	1

第一部分试验_单次给药剂量递增（SAD）试验：主要目的：评估健康成年参与者单次口服QBT-006的安全性和耐受性以及药代动力学特征。初步评估高脂饮食对QBT-006药代动力学的影响。次要目的：初步评价单次给药QBT-006后在健康人体内的药效学指标变化，为后续临床试验设计提供依据。第二部分试验_多次给药剂量递增（MAD）试验主要目的：评估健康成年参与者多次口服QBT-006的安全性和耐受性以及药代动力学特征。次要目的：初步评价多次给药QBT-006后在健康人体内的药效学指标变化，为后续临床试验设计提供依据。

[Translation]

Part I trial_Single ascending dose (SAD) trial: Main purpose: To evaluate the safety, tolerability and pharmacokinetic characteristics of QBT-006 after a single oral administration in healthy adult participants. To preliminarily evaluate the effect of a high-fat diet on the pharmacokinetics of QBT-006. Secondary purpose: To preliminarily evaluate the changes in pharmacodynamic indicators in healthy humans after a single administration of QBT-006, and provide a basis for the design of subsequent clinical trials. Part II trial_Multiple ascending dose (MAD) trial Main purpose: To evaluate the safety, tolerability and pharmacokinetic characteristics of QBT-006 after multiple oral administration in healthy adult participants. Secondary purpose: To preliminarily evaluate the changes in pharmacodynamic indicators in healthy humans after multiple administrations of QBT-006, and provide a basis for the design of subsequent clinical trials.

Start Date18 Apr 2025

Sponsor / Collaborator

Qingbaixinda (Shanghai) Pharmaceutical Technology Co., Ltd.

100 Clinical Results associated with Qingbaixinda (Shanghai) Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Qingbaixinda (Shanghai) Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Qingbaixinda (Shanghai) Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Qingbaixinda (Shanghai) Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data